Two Sigma Advisers’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Two Sigma Advisers’s Portfolio TARO Stock Details TARO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-7,300	Closed	-$305K	–	2682
2023 Q4	$305K	Sell	7,300 -5,713	-44%	-$211K	﹤0.01%	2094
2023 Q3	$491K	Buy	+13,013	New	+$488K	﹤0.01%	1799
2020 Q1	–	Sell	-5,100	Closed	-$448K	–	2595
2019 Q4	$448K	Buy	5,100 +1,100	+28%	+$92.8K	﹤0.01%	1916
2019 Q3	$302K	Sell	4,000 -100	-2%	-$8.12K	﹤0.01%	1920
2019 Q2	$350K	Buy	4,100 +1,200	+41%	+$119K	﹤0.01%	1950
2019 Q1	$313K	Buy	2,900 +200	+7%	+$19.9K	﹤0.01%	1974
2018 Q4	$229K	Buy	2,700 +300	+13%	+$28.9K	﹤0.01%	2088
2018 Q3	$236K	Buy	+2,400	New	+$260K	﹤0.01%	2035
2016 Q1	–	Sell	-2,900	Closed	-$448K	–	2159
2015 Q4	$448K	Sell	2,900 -4,500	-61%	-$657K	﹤0.01%	1371
2015 Q3	$1.06M	Buy	+7,400	New	+$1.03M	0.01%	990
2014 Q4	–	Sell	-1,800	Closed	-$277K	–	2848
2014 Q3	$277K	Buy	+1,800	New	+$271K	﹤0.01%	1929

Other funds holding TARO

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return

Two Sigma Advisers's TARO Position: Q1 2024 in Review

Two Sigma Advisers sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q1 2024, closing a stake of 7,300 shares — an estimated $305K sold.

Two Sigma Advisers first reported a position in TARO in Q3 2014 and held it in 11 quarters. The position peaked at $1.06M in Q3 2015. 94 funds tracked by Wall St. Rank hold TARO as of Q1 2024.

Two Sigma Advisers reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q1 2024 after selling out during the quarter.
Two Sigma Advisers sold 7,300 Taro Pharmaceutical Industries Ltd. shares in Q1 2024, an estimated $305K.
Two Sigma Advisers first reported a position in Taro Pharmaceutical Industries Ltd. in Q3 2014 and held it in 11 quarters.
Two Sigma Advisers's Taro Pharmaceutical Industries Ltd. position peaked at $1.06M in Q3 2015.
94 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q1 2024.

Based on Two Sigma Advisers's 13F filing for Q1 2024, filed 15 May 2024.